Is CCR5-Δ32 mutation associated with diabetic nephropathy in type 2 diabetes?

Annals of Saudi Medicine

Volumn 29, Issue 5, 2009, Pages 413-

  Arababadi, Mohammad Kazemi ^a   Naghavi, Nima ^a   Hassanshahi, Gholamhossein ^a   Mahmoodi, Mehdi ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; DNA;

ASIAN; CELL FUNCTION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA EXTRACTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INDIAN; LETTER; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; FEMALE; GENETICS; MALE; MUTATION;

DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MUTATION; RECEPTORS, CCR5;

EID: 70350613231     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.4103/0256-4947.55177     Document Type: Letter

References (9)

1. Navratilova Z. Polymorphisms in CCL2&CCL5 chemokines/chemokine receptors genes and their association with diseases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006;150(2):191-204.
2. Kalev I, Oselin K, Parlist P, Zilmer M, Rajasalu T, Podar T, Mikelsaar AV. CC-chemokine receptor CCR5-Δ32 mutation as a modifying pathogenetic factor in type-I diabetes. J Diabetes Complications. 2003;17(6):387-391 (Pubitemid 37315951)
3. Ajuebor MN, Carey JA, Swain MG. CCR5 in T cell-mediated liver diseases: what's going on? J Immunol. 2006;177(4):2039-2045
4. Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G, Mohit M, Hajghani M. NK cells CCR5 expression and its d 32 mutation in Iranian patients with occult hepatitis B infection. Intervirol. Forthcoming 2009.
5. Yang B, Houlberg K, Millward A, Demaine A, Polymorphisms of chemokine and chemokine receptor genes in Type-1 diabetes mellitus and its complications. Cytokine. 2004 May 7;26(3):114-121
6. Giovanni G, Mehran G, Annalisa B, Paola DS, Babeck G, Paul N, Peter H, Liene NZ, Carani BS, Alberto FU. Lack of association of CCR2-64I and CCR5-Δ32 with type-1 diabetes and latent autoimmune diabetes in adults. Human Immunol. 2003;64:629-632.
7. Prasad P, Tiwari AK, Kumar KM, Ammini AC, Gupta A, Gupta R, Thelma BK. Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet. 2007;8(20):20. (Pubitemid 46629855)
8. Mlynarski WM, Placha GP, Wolkow PP, Bochenski JP, Warram JH, Krolewski AS. Risk of diabetic nephropathy in type-1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect. Diabetes. 2005;54(11):3331-3335
9. Mokubo A, Tanaka Y, Nakajima K, Watada H, Hirose T, Kawasumi M, Sakai K, Kanazawa A, Maeda S, Hosokawa K, Atsumi Y, Matsuoka K, Kawamori R. Chemotactic cytokine receptor 5 (CCR5) gene promoter polymorphism (59029A/G) is associated with diabetic nephropathy in Japanese patients with type-2 diabetes: a 10-year longitudinal study. Diabetes Res Clin Pract. 2006;73(1):89-94. (Pubitemid 44226300)